<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01440673</url>
  </required_header>
  <id_info>
    <org_study_id>GIRBA2085</org_study_id>
    <nct_id>NCT01440673</nct_id>
  </id_info>
  <brief_title>Aprepitant for Postoperative Nausea and Vomiting in Laparoscopic Hysterectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Gynecological surgery is associated with a high incidence of postoperative nausea and
           vomiting.

        -  NK1 receptor antagonists such as aprepitant appear to be highly effective for treating
           acute and delayed emesis, and yet understanding of the efficacy of different doses of
           aprepitant is limited.

        -  We performed a prospective, randomized, double-blinded placebo-controlled study of 123
           female adults scheduled for laparoscopic hysterectomy who received 80 mg aprepitant, 125
           mg aprepitant, or a placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      123 female patients (ages 21-60) undergoing laparoscopic hysterectomy

        1. 80mg aprepitant

        2. 125mg aprepitant

        3. placebo

      Incidences of nausea, vomiting/retching, and use of rescue antiemetics were recorded at 0, 1,
      2, 24, and 48 h after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The numbers (and percentages) of patients who experienced complete response</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>The numbers (and percentages) of patients who experienced complete response, i.e. no nausea, retching, vomiting, or need for rescue treatment
required rescue therapy and peak nausea scores
Adverse effects in the three treatment groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>aprepitant 125mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NK1 receptor antagonist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aprepitant 80 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aprepitant</intervention_name>
    <description>Aprepitant 80 mg, Aprepitant 125 mg</description>
    <arm_group_label>aprepitant 125mg</arm_group_label>
    <arm_group_label>Aprepitant 80 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female laparoscopic hysterectomy isoflurane anesthesia postoperative opioid use

        Exclusion Criteria:

          -  liver disease neurologic disease active pulmonary disease cardiac arrhythmia allergies
             to any perioperative medications
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WOL SEON JUNG, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gil Medical Center Gachon University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gil Medical Center Gachon University</name>
      <address>
        <city>Inchon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2011</study_first_submitted>
  <study_first_submitted_qc>September 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2011</study_first_posted>
  <last_update_submitted>September 23, 2011</last_update_submitted>
  <last_update_submitted_qc>September 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Medical Center</investigator_affiliation>
    <investigator_full_name>Wol Seon Jung</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Postoperative Nausea and Vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aprepitant</mesh_term>
    <mesh_term>Fosaprepitant</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

